Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EpiCept™ NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy (DPN)

To see complete record on, please visit this link

Id: NCT00476151

Organisation Name: EpiCept Corporation

Overal Status: Completed

Start Date: July 2007

Last Update: May 17, 2011

Lead Sponsor: EpiCept Corporation

Brief Summary: This is a multicenter, randomized, placebo-controlled, parallel group study of EpiCept™ NP-1 Topical Cream (amitriptyline 4%/ketamine 2%) in approximately 200 patients with pain in the lower extremities due to diabetic nerve pain.

  • Diabetic Peripheral Neuropathy
  • Neuralgia

Total execution time in seconds: 0.25570607185364